Low Margins And Ongoing LossesSustained low gross margin (~7.4%) and a TTM net loss (~-4.8%) constrain the company's ability to generate durable profitability from revenue. Low margin structure limits reinvestment capacity and makes long-term viability dependent on sizable margin expansion or structural cost reduction.
Revenue Contraction And Weakening ScaleAn ~11.6% revenue decline despite a multi-year scale improvement weakens operating leverage and makes recent cash flow gains fragile. Without reaccelerating top-line growth, sustaining investment in product and market share will be difficult, risking longer-term competitiveness.
Nasdaq Minimum Bid Price NoncomplianceA formal Nasdaq minimum bid price deficiency starts a 180-day cure window, creating material delisting risk. Addressing it may require dilutive or operational actions (reverse split, buyback, strategic restructuring), diverting management focus and potentially reducing liquidity and investor access over months.